The effect of preseasonal immunotherapy on the production of histamine-refeasing factor (HRF) by mononuclear cells from patients with seasonal asthma: Results of a double-blind, placebo-controlled, randomized study
- 1 April 1989
- journal article
- research article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 83 (4), 816-824
- https://doi.org/10.1016/0091-6749(89)90020-1
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Histamine-releasing factors and IgE heterogeneityJournal of Allergy and Clinical Immunology, 1988
- 229 Purification and characterization of human mononuclear cell-derived histamine releasing factorsJournal of Allergy and Clinical Immunology, 1988
- Isotypic and antigenic restriction of the blocking antibody response to ryegrass pollen: Correlation of rye group I antigen-specific IgG1 with clinical responseJournal of Allergy and Clinical Immunology, 1987
- The magnitude of the spontaneous production of histamine-releasing factor (HRF) by lymphocytes in vitro correlates with the state of bronchial hyperreactivity in patients with asthmaJournal of Allergy and Clinical Immunology, 1987
- A study of histamine release from human basophils and lung mast cells by products of lymphocyte stimulationInflammation Research, 1983
- Clinical and immunologic evaluation of glutaraldehyde-modified, tyrosine-adsorbed short ragweed extract: a double-blind, placebo-controlled trialJournal of Allergy and Clinical Immunology, 1981
- Generation of Antigen-Specific Suppressor Cells during Allergy DesensitizationNew England Journal of Medicine, 1980
- Chemical Modification of Crude Timothy Grass Pollen ExtractInternational Archives of Allergy and Immunology, 1977
- A metabolizable adjuvant: clinical trial of grass pollen-tyrosine adsorbateClinical and Experimental Allergy, 1974
- Procedures for immunochemical study of histamine release from leukocytes with small volume of bloodJournal of Allergy, 1970